The presence of the SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4 (SMARCA4) are co-mutations in KRAS-mutated NSCLC (nearly 10% of cases) and are associated with poor immunotherapy outcomes [222,223,224,225]. Here, KRAS is linked to non-small cell lung carcinoma.